Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Vitamin C in Post-cardiac Arrest Syndrome
NCT03509662Phase 2Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2019
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ascorbic acid in post-cardiac arrest syndrome (PCAS) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Delta Sequential Organ Failure Assessment Score at 96 hours. Started Oct 2019; status: completed.
02
Drugs
ascorbic acid
03
Conditions
post-cardiac arrest syndrome (PCAS)
Beyond the preview
Go deeper on NCT03509662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03509662.